9258 Wealth Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-2,364
Closed -$236K – 371
2021
Q4
$236K Sell
2,364
-40
-2% -$4.14K 0.05% 330
2021
Q3
$301K Hold
2,404
– – 0.08% 259
2021
Q2
$299K Buy
2,404
+80
+3% +$10.8K 0.08% 265
2021
Q1
$355K Buy
2,324
+4
+0.2% +$605 0.11% 207
2020
Q4
$299K Sell
2,320
-83
-3% -$9.55K 0.1% 228
2020
Q3
$256K Buy
+2,403
New +$220K 0.1% 224

Other funds holding GH

9258 Wealth Management's GH Position: Q1 2022 in Review

9258 Wealth Management sold out of Guardant Health (GH) in Q1 2022, closing a stake of 2,364 shares — an estimated $236K sold.

9258 Wealth Management first reported a position in GH in Q3 2020 and held it in 6 quarters. The position peaked at $355K in Q1 2021. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • 9258 Wealth Management reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • 9258 Wealth Management sold 2,364 Guardant Health shares in Q1 2022, an estimated $236K.
  • 9258 Wealth Management first reported a position in Guardant Health in Q3 2020 and held it in 6 quarters.
  • 9258 Wealth Management's Guardant Health position peaked at $355K in Q1 2021.
  • 356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on 9258 Wealth Management's 13F filing for Q1 2022, filed 13 May 2022.